Hims Pops After Novo Nordisk Expected to Make Obesity Drugs Available on Its Telehealth Platform
Shares of Hims surged in premarket trading after reports that Novo Nordisk will place its weight-loss drugs on the telehealth platform of Hims & Hers Health, a possible restoration of ties that broke down amid litigation. The move lifted Hims stock sharply and nudged Novo Nordisk shares higher in Copenhagen.